Hyperparathyroidism Secondary to Hyperaldosteronism

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.17, Iss.1, 2010-03, pp. : 27-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spotlight on Paricalcitol in Secondary Hyperparathyroidism

By Robinson Dean M. Scott Lesley J.

Treatments in Endocrinology, Vol. 4, Iss. 3, 2005-01 ,pp. : 185-186

Adis International

Access to resources Recommend Favorite

Coeliac disease in subjects with secondary hyperparathyroidism

By Jorde R. Saleh F. Sundsfjord J. Haug E. Skogen B.

Scandinavian Journal of Gastroenterology, Vol. 40, Iss. 2, 2005-02 ,pp. : 178-182

Informa Healthcare

Access to resources Recommend Favorite

Simultaneous medullary and papillary microcarcinoma of thyroid in a patient with secondary hyperparathyroidism

By Behrend Matthias Wasielewski Reinhard Brabant Georg

Endocrine Pathology, Vol. 13, Iss. 1, 2002-03 ,pp. : 65-73

Humana Press, Inc

Access to resources Recommend Favorite

Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl

By Eriguchi Rieko Umakoshi Junko Tominaga Yoshihiro Sato Yuzuru

NDT PLUS, Vol. 1, Iss. 4, 2008-08 ,pp. : 218-220

Oxford University Press

Access to resources Recommend Favorite

Vitamin D Analogs: New Therapeutic Agents for Secondary Hyperparathyroidism

By Brown A.J. Coyne D.W.

Treatments in Endocrinology, Vol. 1, Iss. 5, 2002-01 ,pp. : 313-327

Adis International

Access to resources Recommend Favorite